Biomarkers in Drug discovery and development


This biomarker conference throws light on the use of biomarkers in drug development which has emphasised the use of biomarkers as surrogate end points for effectiveness. Biomarkers enhances the understanding of the mechanism of action, enables the assessment of target engagement, facilitates early proof of dose focusing and increases the efficiency of early clinical development with improved quality of decision making, these concepts help in the drug discovery and development process.



 


    Related Conference of Biomarkers in Drug discovery and development

    November 16-17, 2026

    8th International Conference on Biochemistry

    Tokyo, Japan
    November 25-26, 2026

    30th World Congress on Biotechnology

    Rome, Italy
    December 01-02, 2026

    21st World Congress on Biomarkers, Cancer Therapy & Clinical Research

    Dubai, UAE
    January 18-19, 2027

    7th Annual Congress on Antibiotics and Bacterial Infections

    Paris, France
    January 20-21, 2027

    33nd Asia Pacific Biotechnology Congress

    Dubai, UAE
    March 15-16, 2027

    8th Annual Congress on Biosimilars and Future Biotherapeutics

    San Francisco, USA
    April 27-28, 2027

    30th European Biotechnology Congress

    Paris, France
    June 07-08, 2027

    42nd International Conference on Next-Gen Biotechnology and Applications

    Atlanta, USA
    June 07-08, 2027

    28th Biotechnology Congress: Research & Innovations

    Atlanta, USA
    July 21-22, 2027

    28th Global Summit on Analytical and Bioanalytical Techniques

    Paris, France
    September 20-21, 2027

    31st Global Congress on Biotechnology

    Berlin, Germany

    Biomarkers in Drug discovery and development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in